Your browser doesn't support javascript.
loading
Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma.
Dréau, Didier; Moore, Laura Jeffords; Wu, Mike; Roy, Lopa Das; Dillion, Lloye; Porter, Travis; Puri, Rahul; Momin, Noor; Wittrup, K Dane; Mukherjee, Pinku.
Affiliation
  • Dréau D; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, United States.
  • Moore LJ; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, United States.
  • Wu M; OncoTab Inc., Charlotte, NC, United States.
  • Roy LD; OncoTab Inc., Charlotte, NC, United States.
  • Dillion L; OncoTab Inc., Charlotte, NC, United States.
  • Porter T; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, United States.
  • Puri R; OncoTab Inc., Charlotte, NC, United States.
  • Momin N; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Wittrup KD; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Mukherjee P; Department of Biological Sciences, UNC Charlotte, Charlotte, NC, United States.
Front Oncol ; 9: 330, 2019.
Article in En | MEDLINE | ID: mdl-31114758
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Screening_studies Language: En Journal: Front Oncol Year: 2019 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Screening_studies Language: En Journal: Front Oncol Year: 2019 Type: Article Affiliation country: United States